Current Primary Health Guidelines for Adolescent Mental Health in New Zealand
The primary health guidelines for managing adolescent mental health in New Zealand recommend annual universal screening of youth 12 years and older for depression, systematic assessment procedures, and a structured approach to treatment based on severity of symptoms. 1
Practice Preparation and Identification
Practice Organization
- PC clinicians should work with administration to organize clinical settings to reflect best practices in integrated/collaborative care models 1
- Clinicians should seek training in depression assessment, identification, diagnosis, and treatment 1
- Establish referral networks and collaborations with mental health resources in the community 1
Screening and Identification
- Annual universal screening for depression for all adolescents ages 12 years and older using formal self-report screening tools 1
- Identification of depression in youth who are at high risk 1
- Systematic assessment procedures using:
- Reliable depression scales
- Patient and caregiver interviews
- DSM-5 criteria 1
Treatment Approach
Initial Management Based on Severity
Mild Depression:
Moderate to Severe Depression:
- Consultation with mental health specialists should be considered 1
- Treatment with evidence-based medication and psychotherapeutic approaches 1
- Options include:
- Cognitive Behavioral Therapy (CBT) - shown to improve outcomes for adolescents with depression 1
- Interpersonal Therapy for Adolescents (IPT-A) - effective in reducing severity of depression, suicidal ideation, and hopelessness 1
- Medication (for moderate to severe cases) - typically starting with SSRIs 1, 2
Medication Management
- For adolescents (12-17 years), the recommended starting dose for SSRIs like escitalopram is 10 mg daily, with possible increments up to 20 mg 2
- Close monitoring of side effects, particularly during the first 1-2 weeks of treatment 2
- Special attention to monitoring for suicidal ideation, especially for patients under 24 years 2
Ongoing Management
- Ongoing tracking of outcomes using standardized instruments 1
- Continue treatment with SSRIs for at least 12-24 months after achieving remission 2
- Response should be evaluated after 4 and 8 weeks using standardized instruments 2
- Specific steps to be taken in instances of partial or no improvement after initial treatment 1
Implementation Challenges
Despite these guidelines, research shows significant gaps in adolescent mental health care in New Zealand:
- 82% of New Zealand secondary school students with significant mental health problems do not seek help from general practitioners 3
- Help-seeking rates increase with age for girls but decrease with age for boys 3
- Under-funding of Child and Adolescent Mental Health Services (CAMHS) remains a concern 4
School-Based Interventions
School-based interventions are particularly important in the New Zealand context:
- Targeted group-based interventions and CBT in schools are effective in reducing depressive symptoms and anxiety 5
- Being well known by a teacher is associated with increased help-seeking behavior 3
- School-based mental health services can help overcome the low utilization of community-based clinics 6
Common Pitfalls to Avoid
- Delayed identification: Only 50% of adolescents with depression are diagnosed before reaching adulthood 1
- Inadequate treatment: Even when diagnosed by PC providers, only half of patients are treated appropriately 1
- Failure to establish safety plans: Essential for all adolescents with depression 1
- Starting medications at high doses: Risk of suicidal events is higher at the start of treatment and more likely if SSRIs are initiated at higher doses 2
- Inadequate follow-up: Quick and consistent follow-up with a team approach increases compliance and engagement 1
By following these guidelines and addressing these common pitfalls, primary care providers can significantly improve the identification and management of adolescent mental health issues in New Zealand.